Brief: Angle Signs New Commercial Agreement With Astrazeneca

Cellbxhealth

24/04/2024 07:44

April 24 (Reuters) - Angle PLC  AGLE.L :
    * NEW COMMERCIAL AGREEMENT WITH ASTRAZENECA
    * SIGNS AGREEMENT TO TAILOR EXISTING PARSORTIX-BASED DNA
DAMAGE
RESPONSE ASSAY FOR USE IN PHARMACEUTICAL RESEARCH AND
DEVELOPMENT



 ((Reuters.Briefs@thomsonreuters.com;;))